Paisdzior, S.;                     Knierim, E.;                     Kleinau, G.;                     Biebermann, H.;                     Krude, H.;                     Straussberg, R.;                     Schuelke, M.    
        A New Mechanism in THRA Resistance: The First Disease-Associated Variant Leading to an Increased Inhibitory Function of THRA2. Int. J. Mol. Sci. 2021, 22, 5338.
    https://doi.org/10.3390/ijms22105338
    AMA Style
    
                                Paisdzior S,                                 Knierim E,                                 Kleinau G,                                 Biebermann H,                                 Krude H,                                 Straussberg R,                                 Schuelke M.        
                A New Mechanism in THRA Resistance: The First Disease-Associated Variant Leading to an Increased Inhibitory Function of THRA2. International Journal of Molecular Sciences. 2021; 22(10):5338.
        https://doi.org/10.3390/ijms22105338
    
    Chicago/Turabian Style
    
                                Paisdzior, Sarah,                                 Ellen Knierim,                                 Gunnar Kleinau,                                 Heike Biebermann,                                 Heiko Krude,                                 Rachel Straussberg,                                 and Markus Schuelke.        
                2021. "A New Mechanism in THRA Resistance: The First Disease-Associated Variant Leading to an Increased Inhibitory Function of THRA2" International Journal of Molecular Sciences 22, no. 10: 5338.
        https://doi.org/10.3390/ijms22105338
    
    APA Style
    
                                Paisdzior, S.,                                 Knierim, E.,                                 Kleinau, G.,                                 Biebermann, H.,                                 Krude, H.,                                 Straussberg, R.,                                 & Schuelke, M.        
        
        (2021). A New Mechanism in THRA Resistance: The First Disease-Associated Variant Leading to an Increased Inhibitory Function of THRA2. International Journal of Molecular Sciences, 22(10), 5338.
        https://doi.org/10.3390/ijms22105338